MarketWatch

Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation

The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
MORE